Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received June 6, 2012
- Accepted September 10, 2012
- First Published December 19, 2012.
Article Versions
- Previous version (December 19, 2012 - 13:01).
- You are viewing the most recent version of this article.
Author Disclosures
- Rik Ossenkoppele, MSc,
- Wiesje M. van der Flier, PhD,
- Marissa D. Zwan, MSc,
- Sofie F. Adriaanse, MSc,
- Ronald Boellaard, PhD,
- Albert D. Windhorst, PhD,
- Frederik Barkhof, PhD,
- Adriaan A. Lammertsma, PhD,
- Philip Scheltens, PhD and
- Bart N.M. van Berckel, PhD
- Rik Ossenkoppele, MSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Wiesje M. van der Flier, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Marissa D. Zwan, MSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Sofie F. Adriaanse, MSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ronald Boellaard, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Albert D. Windhorst, PhD,
NONE
NONE
NONE
SAB member since 3 years of Journal of labelled compounds and radiopharmaceuticals, SAB member since 2 years of Current Radiopharmaceuticals,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Frederik Barkhof, PhD,
Scientific consultant to Bayer-Schering, Sanofi- Aventis, Synthon, Novartis, Biogen-Idec, Merck-Serono, GE medical systems, Roche, Janssen, Genzyme
NONE
NONE
Editorial board member for Brain, Eur Radiol, J Neurol, Neuroradiology
NONE
NONE
Serono Symposia speaker 2009, 2010 and 2011, Novartis symposium speaker 2009, 2010 and 2011, BioClinica symposium speaker 2010, Bayer-Schering symposium speaker 2010
Consultant for Sanofi-Aventis, Synthon, Janssen, Novartis, Biogen-Idec, GE medical systems, Roche
NONE
NONE
NONE
NONE
NONE
NONE
Dutch foundation for MS Research - centre grant 2010-2014
NONE
NONE
NONE
NONE
NONE
NONE
- Adriaan A. Lammertsma, PhD,
1. Scientific Advisory Board "Center for Integrated Oncology Köln Bonn" - no compensation received
NONE
NONE
1. Guest editor Medical Physics, 2. Guest editor International Journal of Molecular Imaging, 3. Section editor Nuklearmedizin, 4. International associate editor Molecular Imaging and Biology, 5. Editorial Board European Joeurnal of Nuclear Medicine and Molecular Imaging, 6. Editorial Board Journal of Cerebral Blood Flow and Metabolism
NONE
NONE
NONE
NONE
NONE
NONE
NONE
1. Research support (oncology) by Hoffman-La Roche, 2. Research support (imaging technology) by Philips
3. European community grant for FP7 integrative project: INMiND - neuroinflammation in neurodegeneration
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Philip Scheltens, PhD and
Advisory boards of: Danone Research, Wyeth/Elan, BMS, Genentech, Pfizer, GE healthcare, jansen AI, Merck
NONE
Lundbeck, educational symposium, 2009, 2012, Nutricia, CTAD 2011 and AAIC 2012, Jansen AI, EFNS 2012
NONE
NONE
NONE
NONE
Pfizer, GE Healthcare, AVID/Lilly, genentech, Jansen AI, Danone.
NONE
NONE
NONE
NONE
NONE
NONE
Alzheimer Nederland; sponsor Alzheimer Center, from 2000 onwards, Stichting VUmc fonds: sponsor Alzheimer Center from 2005 onwards, Innovation Fund: sponsor of Center 2009-2014
NONE
NONE
NONE
NONE
NONE
NONE
- Bart N.M. van Berckel, PhD
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
American health Assistance Foundation, Internationale Stichting Alzheimer onderzoek, Alzheimer Association, Center for Translational Molecular Medicine
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology & Alzheimer Center (R.O., W.M.v.d.F., M.D.Z., S.F.A., P.S.), Department of Nuclear Medicine & PET Research (R.O., M.D.Z., S.F.A., R.B., A.D.W., A.A.L., B.N.M.v.B.), and Departments of Epidemiology & Biostatistics (W.M.v.d.F.) and Radiology (F.B.), VU University Medical Center, Amsterdam, the Netherlands.
- Correspondence to R. Ossenkoppele: r.ossenkoppele{at}vumc.nl
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Cutaneous α-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson Disease
Dr. Rizwan S. Akhtar and Dr. Sarah Brooker
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Articles
Imaging β-amyloid burden in aging and dementiaC. C. Rowe, S. Ng, U. Ackermann et al.Neurology, May 14, 2007 -
Article
Multitracer model for staging cortical amyloid deposition using PET imagingLyduine E. Collij, Fiona Heeman, Gemma Salvadó et al.Neurology, July 16, 2020 -
Articles
Conversion of amyloid positive and negative MCI to AD over 3 yearsAn 11C-PIB PET studyA. Okello, J. Koivunen, P. Edison et al.Neurology, July 08, 2009 -
Article
Association of APOE4 and Clinical Variability in Alzheimer Disease With the Pattern of Tau- and Amyloid-PETRenaud La Joie, Adrienne V. Visani, Orit H. Lesman-Segev et al.Neurology, December 01, 2020